Aldesleukin Terminated Phase 1 Trials for Metastatic Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00923806Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer